Literature DB >> 10396391

Reliability of drop size from multi-dose eye drop bottles: is it cause for concern?

E J German1, M A Hurst, D Wood.   

Abstract

PURPOSE: Responses to topically applied ocular drugs vary between patients. The volume of drug instilled is of particular importance as one of many sources of response variation, but the reliability of drop volume from eye drop bottles is unknown. Hence, the repeatability of drop volume and factors affecting this for a variety of drug manufacturers were considered in this study.
METHODS: Nineteen bottles, one from each primary manufacturer in the UK, were examined. The mass of all drops expelled from each bottle was measured with respect to the bottle type, handling angle, drop number, drug and concentration. The accuracy (repeatability and trueness) of drops from each bottle was also evaluated.
RESULTS: Drop volume varied significantly between drug manufacturers, ranging from 33.8 microliters to 63.4 microliters. The handling angle of the bottle also influenced drop volume, with angles less than 60 degrees giving smaller drops. Drop number exhibited no significant effect upon drop volume. However, the drug type and its concentration did significantly affect the volume of the drop expelled from the bottle, with higher concentrations giving rise to larger drops. Repeatability coefficients across the range of bottles varied between +/- 2.24 microliters and +/- 10.76 microliters (mean +/- 5.07 microliters).
CONCLUSIONS: It is well reported that drug volume instilled has a significant effect on the degree of response. However, there are currently no official regulations concerning eye drop volume in either the UK or the USA. Since drop volume has been shown to vary significantly depending upon a variety of factors, it may be appropriate that the regulatory bodies consider the consequences of variable drop size.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10396391     DOI: 10.1038/eye.1999.17

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

1.  Sustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials.

Authors:  Rahul Garhwal; Sally F Shady; Edward J Ellis; Jeanne Y Ellis; Charles D Leahy; Stephen P McCarthy; Kathryn S Crawford; Peter Gaines
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-13       Impact factor: 4.799

2.  Simulation of the hydrodynamic conditions of the eye to better reproduce the drug release from hydrogel contact lenses: experiments and modeling.

Authors:  A F R Pimenta; A Valente; J M C Pereira; J C F Pereira; H P Filipe; J L G Mata; R Colaço; B Saramago; A P Serro
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

3.  Silver and fluoride content and short-term stability of 38% silver diamine fluoride.

Authors:  Yasmi O Crystal; Sasan Rabieh; Malvin N Janal; Sarunphorn Rasamimari; Timothy G Bromage
Journal:  J Am Dent Assoc       Date:  2019-02       Impact factor: 3.634

4.  Effect of Particle Size and Viscosity of Suspensions on Topical Ocular Bioavailability of Budesonide, a Corticosteroid.

Authors:  Sunil Vooturi; David Bourne; Jiban Jyoti Panda; Stephanie Choi; Hyewon Kim; Sarath K Yandrapu; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2020-07-14       Impact factor: 2.850

5.  Novel topical ophthalmic formulations for management of glaucoma.

Authors:  Mohammed M Ibrahim; Abd-Elgawad H Abd-Elgawad; Osama A Soliman; Monica M Jablonski
Journal:  Pharm Res       Date:  2013-06-15       Impact factor: 4.200

6.  Efficacy of daily 800 IU vitamin D supplementation in reaching vitamin D sufficiency in nursing home residents: cross-sectional patient file study.

Authors:  Bistra I Veleva; Victor G Chel; Wilco P Achterberg
Journal:  BMC Geriatr       Date:  2014-09-19       Impact factor: 3.921

7.  A novel TRPM8 agonist relieves dry eye discomfort.

Authors:  Jee Myung Yang; Fengxian Li; Qin Liu; Marco Rüedi; Edward Tak Wei; Michael Lentsman; Hyo Seok Lee; Won Choi; Seong Jin Kim; Kyung Chul Yoon
Journal:  BMC Ophthalmol       Date:  2017-06-26       Impact factor: 2.209

8.  Efficacy and safety of fluocinolone acetonide 0.025% otic solution in patients with otic eczema: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Victoria Montoro; Carlos Asensio; Ángel Martínez; Juan Lorente; Francisco J Rodríguez; José Montojo; Javier Gavilanes; Pedro Sarría; Cristóbal Langdon; Eduard Prades
Journal:  J Int Med Res       Date:  2018-08-24       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.